Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome.
Ponticelli
C
C
Divisione di Nefrologia e Dialisi, Istituto Scientifico Ospedale Maggiore, Milano, Italy.
Passerini
P
P
D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000188:drug therapy*
D000477:Alkylating Agents; D007166:Immunosuppressive Agents; D001379:Azathioprine